Medi-Caps Current Liabilities
The Current Liabilities of Medi-Caps (523144.BO) as of Oct 9, 2026 is 10.12 M INR. In the previous year, Current Liabilities was 30.99 M INR — a change of -67.34% (lower).
Get this data via API
Financial Data API
Current Liabilities
10.12 MINR
YoY
-67.34%
Last updated:
The Medi-Caps Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 10.12 MINR | -67.34% | |
| 30.99 MINR | +41.56% | |
| 21.89 MINR | -30.80% | |
| 31.63 MINR | -73.66% | |
| 120.10 MINR | +59.98% | |
| 75.07 MINR | +214.25% | |
| 23.89 MINR | -69.90% | |
| 79.37 MINR | +2.76% | |
| 77.24 MINR | +40.08% | |
| 55.14 MINR | -31.81% | |
| 80.86 MINR | +45.80% | |
| 55.46 MINR | -59.04% | |
| 135.40 MINR | +189.32% | |
| 46.80 MINR | -15.83% | |
| 55.60 MINR | -14.59% | |
| 65.10 MINR | +37.63% | |
| 47.30 MINR | +3.50% | |
| 45.70 MINR | -12.79% | |
| 52.40 MINR | +11.49% | |
| 47.00 MINR | — |
Medi-Caps Stock analysis
Frequently Asked Questions about Medi-Caps stock
Current Liabilities of Medi-Caps is 10.12 M INR in 2026.
Current Liabilities of Medi-Caps changed from 30.99 M INR to 10.12 M INR, representing a -67.34% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Medi-Caps since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Medi-Caps historically and in real time.
Balance Sheet — Medi-Caps
All Key Metrics — Medi-Caps
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth